<DOC>
	<DOC>NCT00219037</DOC>
	<brief_summary>Assess the long-term safety and tolerability of aliskiren, with the optional addition of HCTZ, in patients with essential hypertension, to ensure long term blood pressure control and protect against end organ damage.</brief_summary>
	<brief_title>Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Inclusion Criteria 1. Patients with essential hypertension. 2. Patients who are eligible and able to participate in the study. Exclusion Criteria 1. Severe hypertension. 2. History or evidence of a secondary form of hypertension. 3. History of hypertensive encephalopathy or cerebrovascular accident. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Hypertension, blood pressure, aliskiren</keyword>
</DOC>